Mark Wilhelm

Mark Wilhelm has extensive experience in national accounts and sales management. Their most recent position is as Senior Director and Head of National Payer Accounts at Galderma, where they began in November 2023. Prior to that, they served as Senior Director of National Accounts at Alnylam Pharmaceuticals from December 2021 to November 2023. Before that, Mark held various roles at Biogen, starting as a Senior Director of National Accounts from October 2019 to December 2021. Mark also worked as a National Account Director and Sr. National Account Manager at Biogen. Mark's career began at Pfizer in 1996 as an Account Manager, and they later held positions at Schering Plough and Cisco before joining UCB as a Federal Account Executive. Mark eventually became the National Director of Federal Accounts at UCB. Mark's work experience showcases their expertise in national accounts and their ability to excel in leadership roles.

Mark Wilhelm received their Bachelor of Science (BS) degree in Accounting from the University of Pittsburgh from 1989 to 1993. In addition to their degree, they also obtained a certification in the Biogen ARC Leadership Program from Babson College in September 2021.